Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Lee Jackson | Dec 31, 2017 at 10:15 AM EST

Analysts Have 12 Top Biotech Picks for Big Upside in 2018

There can be some big biotech winners in 2018, given the changing landscape, and any of these 12 could be…

Chris Lange | Dec 30, 2017 at 8:55 AM EST

30 Big Biotech Events Coming in 2018

Jefferies has compiled a list of over 30 biotech events taking place in 2018 that could result in significant stock…

Chris Lange | Dec 29, 2017 at 11:35 AM EST

Atara Biotherapeutics Wins FDA Clearance for Late-Stage Trials

Atara Biotherapeutics shares surged on Friday after the firm announced that it received clearance from the FDA to initiate two…

Chris Lange | Dec 29, 2017 at 9:50 AM EST

Progenics Pharma Surges on FDA Decision

Progenics Pharmaceuticals saw its shares make a solid gain to close out the year after the FDA accepted for review…

Chris Lange | Dec 28, 2017 at 11:50 AM EST

Top 10 Biopharma Events Kicking Off 2018

Jefferies has put together a list of 10 biotech companies that could have developments coming up in the next two…

Chris Lange | Dec 28, 2017 at 10:25 AM EST

More and More Short Sellers Raising the Stakes in Major Pharma

The December 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Chris Lange | Dec 28, 2017 at 9:05 AM EST

Major Biotechs See Surge in Short Interest

The December 15 short interest data have been compared with the previous report, and short interest in the selected biotech…

Chris Lange | Dec 27, 2017 at 1:10 PM EST

What Shire Is Planning With Its Newest FDA Submission

Although Shire is not seeing much of a bump in its share price, the firm is creating a lot of…

Chris Lange | Dec 27, 2017 at 11:55 AM EST

Is Teva Finally Back on Track?

Teva Pharmaceutical saw its shares make a small gain on Wednesday after the firm announced the exclusive launch of a…

Jon C. Ogg | Dec 26, 2017 at 11:30 AM EST

Will a Sucampo Acquisition Get Mallinckrodt Back on Track?

Mallinckrodt has seen its shares rise on news that it was acquiring Sucampo Pharmaceuticals for roughly $840 million.

Chris Lange | Dec 22, 2017 at 10:35 AM EST

Why Celgene Shares Took a Step Back

Celgene saw its shares take a step back on Friday after the firm announced results from a late-stage clinical study…

Chris Lange | Dec 21, 2017 at 12:40 PM EST

FDA Accepts Allergan and Paratek’s Newest Acne Treatment for Review

Paratek Pharmaceuticals saw its shares make a handy gain on Thursday after the firm announced that the FDA accepted its…

Lee Jackson | Dec 21, 2017 at 8:25 AM EST

RBC Out With Top Pick Biotech Stocks to Buy for 2018

A new RBC report is reasonably positive on the biotech sector for the coming year. These eight top picks for…

Douglas A. McIntyre | Dec 21, 2017 at 6:35 AM EST

US Life Expectancy Fell Last Year: Official CDC Announcement

The Centers for Disease Control and Prevention (CDC) has announced that the life expectancy of Americans fell last year.

Chris Lange | Dec 20, 2017 at 1:45 PM EST

Exelixis Wins Big With FDA Approval

Exelixis saw its shares make a handy gain on Wednesday after the company received the nod from the FDA for…

1 … 146 147 148 149 150 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Analysts Have 12 Top Biotech Picks for Big Upside in 2018

30 Big Biotech Events Coming in 2018

Atara Biotherapeutics Wins FDA Clearance for Late-Stage Trials

Progenics Pharma Surges on FDA Decision

Top 10 Biopharma Events Kicking Off 2018

More and More Short Sellers Raising the Stakes in Major Pharma

Major Biotechs See Surge in Short Interest

What Shire Is Planning With Its Newest FDA Submission

Is Teva Finally Back on Track?

Will a Sucampo Acquisition Get Mallinckrodt Back on Track?

Why Celgene Shares Took a Step Back

FDA Accepts Allergan and Paratek’s Newest Acne Treatment for Review

RBC Out With Top Pick Biotech Stocks to Buy for 2018

US Life Expectancy Fell Last Year: Official CDC Announcement

Exelixis Wins Big With FDA Approval

AMZW’s Weekly Payouts Drop 79% as Volatility Collapses; Can Investors Count on Them?

The Reverse Mortgage Line of Credit That Grows Untouched for 15 Years and Becomes a $700,000 Liquidity Buffer at 80

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

AMZW’s Weekly Payouts Drop 79% as Volatility Collapses; Can Investors Count on Them?

The Reverse Mortgage Line of Credit That Grows Untouched for 15 Years and Becomes a $700,000 Liquidity Buffer at 80

Health and Healthcare Articles

All Health and Healthcare Articles

Analysts Have 12 Top Biotech Picks for Big Upside in 2018

30 Big Biotech Events Coming in 2018

Atara Biotherapeutics Wins FDA Clearance for Late-Stage Trials

Progenics Pharma Surges on FDA Decision

Top 10 Biopharma Events Kicking Off 2018

More and More Short Sellers Raising the Stakes in Major Pharma

Major Biotechs See Surge in Short Interest

What Shire Is Planning With Its Newest FDA Submission

Is Teva Finally Back on Track?

Will a Sucampo Acquisition Get Mallinckrodt Back on Track?

Why Celgene Shares Took a Step Back

FDA Accepts Allergan and Paratek’s Newest Acne Treatment for Review

RBC Out With Top Pick Biotech Stocks to Buy for 2018

US Life Expectancy Fell Last Year: Official CDC Announcement

Exelixis Wins Big With FDA Approval

AMZW’s Weekly Payouts Drop 79% as Volatility Collapses; Can Investors Count on Them?

The Reverse Mortgage Line of Credit That Grows Untouched for 15 Years and Becomes a $700,000 Liquidity Buffer at 80

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Featured Reads

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how